187 related articles for article (PubMed ID: 18163163)
1. Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations.
Lohmann W; Karst U
Anal Bioanal Chem; 2008 May; 391(1):79-96. PubMed ID: 18163163
[TBL] [Abstract][Full Text] [Related]
2. Electrochemistry in the mimicry of oxidative drug metabolism by cytochrome P450s.
Nouri-Nigjeh E; Bischoff R; Bruins AP; Permentier HP
Curr Drug Metab; 2011 May; 12(4):359-71. PubMed ID: 21395527
[TBL] [Abstract][Full Text] [Related]
3. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
Baumann A; Karst U
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
[TBL] [Abstract][Full Text] [Related]
4. Advances in the electrochemical simulation of oxidation reactions mediated by cytochrome p450.
Bussy U; Boujtita M
Chem Res Toxicol; 2014 Oct; 27(10):1652-68. PubMed ID: 25285807
[TBL] [Abstract][Full Text] [Related]
5. Fenton's oxidation: a tool for the investigation of potential drug metabolites.
Kugelmann E; Albert CR; Bringmann G; Holzgrabe U
J Pharm Biomed Anal; 2011 Apr; 54(5):1047-58. PubMed ID: 21232899
[TBL] [Abstract][Full Text] [Related]
6. Oxidative metabolism of 5-o-caffeoylquinic acid (chlorogenic acid), a bioactive natural product, by metalloporphyrin and rat liver mitochondria.
dos Santos MD; Martins PR; dos Santos PA; Bortocan R; Iamamoto Y; Lopes NP
Eur J Pharm Sci; 2005 Sep; 26(1):62-70. PubMed ID: 16019193
[TBL] [Abstract][Full Text] [Related]
7. Lidocaine oxidation by electrogenerated reactive oxygen species in the light of oxidative drug metabolism.
Nouri-Nigjeh E; Permentier HP; Bischoff R; Bruins AP
Anal Chem; 2010 Sep; 82(18):7625-33. PubMed ID: 20735006
[TBL] [Abstract][Full Text] [Related]
8. [Metalloporphyrin catalyzed biomimetic oxidation potentials: potential uses and applications].
Balogh GT; Keserü GM
Acta Pharm Hung; 2003; 73(3):153-62. PubMed ID: 15112438
[TBL] [Abstract][Full Text] [Related]
9. Electrochemistry/mass spectrometry as a tool in metabolism studies-a review.
Faber H; Vogel M; Karst U
Anal Chim Acta; 2014 Jun; 834():9-21. PubMed ID: 24928240
[TBL] [Abstract][Full Text] [Related]
10. Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions.
Jurva U; Wikström HV; Weidolf L; Bruins AP
Rapid Commun Mass Spectrom; 2003; 17(8):800-10. PubMed ID: 12672134
[TBL] [Abstract][Full Text] [Related]
11. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
Tarcsay Á; Keseru GM
Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
[TBL] [Abstract][Full Text] [Related]
12. Electrochemistry-mass spectrometry in drug metabolism and protein research.
Permentier HP; Bruins AP; Bischoff R
Mini Rev Med Chem; 2008 Jan; 8(1):46-56. PubMed ID: 18220984
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors.
Fődi T; Ignácz G; Decsi B; Béni Z; Túrós GI; Kupai J; Weiser DB; Greiner I; Huszthy P; Balogh GT
Chemistry; 2018 Jul; 24(37):9385-9392. PubMed ID: 29736963
[TBL] [Abstract][Full Text] [Related]
14. Use of density functional theory in drug metabolism studies.
Rydberg P; Jørgensen FS; Olsen L
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
[TBL] [Abstract][Full Text] [Related]
15. Electrocatalytic oxidation of hydrogen peroxide on a platinum electrode in the imitation of oxidative drug metabolism of lidocaine.
Nouri-Nigjeh E; Bruins AP; Bischoff R; Permentier HP
Analyst; 2012 Oct; 137(20):4698-702. PubMed ID: 22929863
[TBL] [Abstract][Full Text] [Related]
16. Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesis.
Johansson T; Weidolf L; Jurva U
Rapid Commun Mass Spectrom; 2007; 21(14):2323-31. PubMed ID: 17575570
[TBL] [Abstract][Full Text] [Related]
17. Cunninghamella--a microbial model for drug metabolism studies--a review.
Asha S; Vidyavathi M
Biotechnol Adv; 2009; 27(1):16-29. PubMed ID: 18775773
[TBL] [Abstract][Full Text] [Related]
18. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
[TBL] [Abstract][Full Text] [Related]
19. [Modeling the oxidative detoxication function of the liver using electrochemical oxidation reactions].
Zhirnov GF; Izotov MV; Karuzina II; Lopukhin IuM; Archakov AI
Vopr Med Khim; 1979; 25(2):218-22. PubMed ID: 442594
[TBL] [Abstract][Full Text] [Related]
20. Accessing Drug Metabolites via Transition-Metal Catalyzed C-H Oxidation: The Liver as Synthetic Inspiration.
Genovino J; Sames D; Hamann LG; Touré BB
Angew Chem Int Ed Engl; 2016 Nov; 55(46):14218-14238. PubMed ID: 27723189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
